Medtronic (MDT) Common Equity (2013 - 2026)

Medtronic (MDT) has 14 years of Common Equity data on file, last reported at $50.1 billion in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 4.26% year-over-year to $50.1 billion; the trailing twelve-month figure through Apr 2026 stood at $50.1 billion (up 4.26% YoY), and the FY2026 full-year result was $50.1 billion, up 4.26% from the prior year.
• Common Equity rose to $50.1 billion in Q2 2026, from $49.0 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $52.8 billion in Q3 2022 to a low of $48.0 billion in Q2 2025.
• A 5-year average of $50.5 billion and a median of $50.9 billion in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity dropped 6.24% in 2024 and gained 4.26% in 2026, its largest moves.
• Tracing MDT's Common Equity over 5 years: stood at $52.1 billion in 2022, then declined by 0.79% to $51.6 billion in 2023, then dropped by 5.68% to $48.7 billion in 2024, then grew by 0.29% to $48.9 billion in 2025, then gained by 2.49% to $50.1 billion in 2026.
• Business Quant data shows MDT's Common Equity at $50.1 billion in Q2 2026, $49.0 billion in Q1 2026, and $48.9 billion in Q4 2025.